The DOI matches its Crossref record; 285 of the 285 references it cites were found in a registry or an index.
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
Open accessAbstract
Considerable overlap has been identified in the risk factors, comorbidities and putative pathophysiological mechanisms of Alzheimer disease and related dementias (ADRDs) and type 2 diabetes mellitus (T2DM), two of the most pressing epidemics of our time. Much is known about the biology of each condition, but whether T2DM and ADRDs are parallel phenomena arising from coincidental roots in ageing or synergistic diseases linked by vicious pathophysiological cycles remains unclear. Insulin resistance is a core feature of T2DM and is emerging as a potentially important feature of ADRDs. Here, we review key observations and experimental data on insulin signalling in the brain, highlighting its actions in neurons and glia. In addition, we define the concept of 'brain insulin resistance' and review the growing, although still inconsistent, literature concerning cognitive impairment and neuropathological abnormalities in T2DM, obesity and insulin resistance. Lastly, we review evidence of intrinsic brain insulin resistance in ADRDs. By expanding our understanding of the overlapping mechanisms of these conditions, we hope to accelerate the rational development of preventive, disease-modifying and symptomatic treatments for cognitive dysfunction in T2DM and ADRDs alike.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“in AD and amnestic mild cognitive impairment (aMCI) glucose metabolism is dramatically decreased”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In AD and aMCI, however, brain insulin resistance is present6,7.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glucose enters the brain from the vasculature through highly efficient glucose transporters and requires insulin for optimal cellular utilization7.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Yet glucose metabolism in AD and aMCI brains is significantly impaired5–7,9,38.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The brain is an energy-demanding organ and relies heavily on efficient ATP production via glycolysis, the TCA cycle and oxidative phosphorylation (Fig. 1)7.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [7]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to mTOR activation, insulin resistance can also result in neuronal glucose deficiency, with consequent decreased glucose metabolism, impaired ATP production, and dysfunction and/or death7,42”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The possible action of Al in the pathogenesis of diabetes mellitus and the concurrence of neurological disorders associated with Alzheimer’s disease and other dementias (Arnold et al., 2018) point to the common cellular basis of the pathogenesis of both metabolic and cognitive disorders, which can arise from toxic actions of Al.”
From Aluminium toxicosis: a review of toxic actions and effects (2019) · cites this paper as Arnold et al., 2018
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“insulin resistance could affect neuronal function and Aβ accumulation in the brain, which contribute to neuroinflammation and synaptic dysfunction and finally lead to cognitive decline (Arnold et al., 2018).”
From AD-Like Neuropsychiatric Dysfunction in a Mice Model Induced by a Combination of High-Fat Diet and Intraperitoneal Injection of Streptozotocin (2024) · cites this paper as Arnold et al., 2018
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent studies have suggested a potential link between AD and insulin resistance, which exhibits a decreased level of key insulin signaling proteins and an increased level of insulin resistance markers in the brains of AD mice (Craft et al., 1998; Arnold et al., 2018; Kshirsagar et al., 2021).”
From AD-Like Neuropsychiatric Dysfunction in a Mice Model Induced by a Combination of High-Fat Diet and Intraperitoneal Injection of Streptozotocin (2024) · cites this paper as Arnold et al., 2018
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Indeed, type 2 diabetes (T2DM), a key component of which is insulin resistance, is a significant risk factor for developing AD7.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“These mTOR-mediated events may help explain the observation that type 2 diabetes (T2DM) is a significant risk factor for development of AD7,41.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“Brain insulin resistance is common in AD7,38,41.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [7]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Indeed, mitochondrial dysfunction and insulin resistance are intimately related7,38.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [7]
Experimental — accuracy not yet measuredIn the citing paper
“it might involve the down-regulation or failure of insulin receptors, as well as impairments of downstream signalling, and contribute to the emergence and/or persistence of metabolic dysregulation”
From Intranasal insulin (2021) · cites this paper as [90]
In the citing paper
“Insulin may moreover boost brain energy supply via effects on astrocytes 129 and other glia cells, including oligodentrocytes.90”
From Intranasal insulin (2021) · cites this paper as [90]
In the citing paper
“Respective organ deficits include reductions in hippocampal volume, 141 as well as ischaemic impairments and cortical hypometabolism.90”
From Intranasal insulin (2021) · cites this paper as [90]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–285 of 285
Diabetes as a Predictor of Change in Functional Status Among Older Mexican Americans
Wu, J., Haan, M. N., Liang, J., Ghosh, D., González, H. M., & Herman, W. H. (2003) · Diabetes Care · doi:10.2337/diacare.26.2.314 · Cited by 103
McNay, E. C., & Gold, P. E. (2002) · Behavioral and Cognitive Neuroscience Reviews · doi:10.1177/1534582302238337 · Cited by 103
Werther, G. A., Hogg, A., Oldfield, B. J., McKinley, M. J., Figdor, R., & Mendelsohn, F. A. O. (1989) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1989.tb00131.x · Cited by 102
β‐Amyloid deposition in brains of subjects with diabetes
Alafuzoff, I. I., Aho, L., Helisalmi, S., Mannermaa, A., & Soininen, H. S. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00948.x · Cited by 102
Garwood, C. J., Ratcliffe, L. E., Morgan, S. V., Simpson, J. E., Owens, H., Vazquez-Villaseñor, I., Heath, P. R., Romero, I. A., Ince, P. G., & Wharton, S. B. (2015) · Molecular Brain · doi:10.1186/s13041-015-0138-6 · Cited by 101
Distribution of insulin receptor substrate-2 in brain areas involved in energy homeostasis
Pardini, A. W., Hồng, N. T., Figlewicz, D. P., Baskin, D. G., Williams, D. L., Kim, F., & Schwartz, M. W. (2006) · Brain Research · doi:10.1016/j.brainres.2006.06.109 · Cited by 101
Mid-life and late-life vascular risk factors and dementia in Korean men and women
Kimm, H., Lee, P. H., Shin, Y., Park, K. S., Jo, J., Lee, Y., Kang, H., & Jee, S. H. (2010) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2010.09.004 · Cited by 100
Cui, Y., Liang, X., Gu, H., et al. (2016) · Brain Imaging and Behavior · doi:10.1007/s11682-016-9583-9 · Cited by 99
Reno, C. M., Puente, E. C., Sheng, Z., Daphna-Iken, D., Bree, A. J., Routh, V. H., Kahn, B. B., & Fisher, S. J. (2016) · Diabetes · doi:10.2337/db16-0917 · Cited by 97
Tong, M., Dong, M., & de la Monte, S. M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0995 · Cited by 95
INTRACRANIAL VASCULAR LESIONS IN PATIENTS WITH DIABETES MELLITUS
Aronson, S. M. (1973) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-197304000-00001 · Cited by 92
Diabetes and risk of Parkinson's disease
Cereda, E., Barichella, M., Pedrolli, C., et al. (2012) · Movement Disorders · doi:10.1002/mds.25211 · Cited by 90
SORCS1: A Novel Human Type 2 Diabetes Susceptibility Gene Suggested by the Mouse
Goodarzi, M. O., Lehman, D. M., Taylor, K. D., Guo, X., Cui, J., Quiñones, M. J., Clee, S. M., Yandell, B. S., Blangero, J., Hsueh, W. A., et al. (2007) · Diabetes · doi:10.2337/db06-1677 · Cited by 89
(2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-159002 · Cited by 89
Analysis of tyrosine hydroxylase and insulin transcripts in human neuroendocrine tissues
Coker, G. T., Studelska, D. R., Harmon, S., Burke, W. J., & O’Malley, K. L. (1990) · Molecular Brain Research · doi:10.1016/0169-328x(90)90052-f · Cited by 85
Brain Glucose Transporters: Relationship to Local Energy Demand
Duelli, R., & Kuschinsky, W. (2001) · Physiology · doi:10.1152/physiologyonline.2001.16.2.71 · Cited by 85
Schilling, T. M., de Sá, D. S. F., Westerhausen, R., Strelzyk, F., Larra, M. F., Hallschmid, M., Savaskan, E., Oitzl, M. S., Busch, H., Naumann, E., et al. (2013) · Human Brain Mapping · doi:10.1002/hbm.22304 · Cited by 84
Starks, E. J., O’Grady, J. P., Hoscheidt, S. M., Racine, A. M., Carlsson, C. M., Zetterberg, H., Blennow, K., Okonkwo, O. C., Puglielli, L., Asthana, S., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150072 · Cited by 82
Mielke, J. G., Taghibiglou, C., & Wang, Y. T. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.07.055 · Cited by 81
García‐Casares, N., Jorge, R. E., García-Arnés, J. A., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140702 · Cited by 79
Diabetes mellitus, dementia, and cognitive function in older persons.
Arvanitakis, Z., Wilson, R. S., & Bennett, D. A. (2006) · PubMed · Cited by 79
Self-citationChanges in Glycemic Control are Associated with Changes in Cognition in Non-Diabetic Elderly
Ravona‐Springer, R., Moshier, E. L., Schmeidler, J., Godbold, J., Akrivos, J., Rapp, M. A., Grossman, H. T., Wysocki, M., Silverman, J. M., Haroutunian, V. H., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120106 · Cited by 78
Developmental regulation of insulin in the mammalian central nervous system
Schechter, R., Whitmire, J., Holtzclaw, L. A., George, M., Harlow, R. D., & Devaskar, S. U. (1992) · Brain Research · doi:10.1016/0006-8993(92)90313-x · Cited by 78
Genomic convergence to identify candidate genes for Alzheimer Disease on chromosome 10
Liang, X. S., Slifer, M. A., Martin, E. R., Schnetz‐Boutaud, N. C., Bartlett, J., Anderson, B., Zuchner, S. L., Gwirtsman, H. E., Gilbert, J. R., Pericak‐Vance, M. A., et al. (2008) · Human Mutation · doi:10.1002/humu.20953 · Cited by 77
The Role of Insulin as a Satiety Factor in the Central Nervous System
Woods, S. C., & Porte, D. (1983) · Advances in metabolic disorders · doi:10.1016/b978-0-12-027310-2.50024-4 · Cited by 75
Investigation on the relationship between diabetes mellitus type 2 and cognitive impairment
Ebady, S. A., Arami, M. A., & Shafigh, M. H. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.08.020 · Cited by 75
Krug, R., Benedict, C., Jan Born, A., & Hallschmid, M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0744 · Cited by 74
Genes, Genetics, and Environment in Type 2 Diabetes: Implication in Personalized Medicine
Kaul, N., & Ali, S. (2015) · DNA and Cell Biology · doi:10.1089/dna.2015.2883 · Cited by 74
Hoscheidt, S. M., Kellawan, J. M., Berman, S. E., Rivera‐Rivera, L. A., Krause, R. A., Oh, J. M., Beeri, M. S., Rowley, H. A., Wieben, O. E., Carlsson, C. M., et al. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16663214 · Cited by 74
White Matter Microstructure and Cognitive Function in Young Women With Polycystic Ovary Syndrome
Rees, A., Udiawar, M., Berlot, R., Jones, D. K., & O'Sullivan, M. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2318 · Cited by 72
Berhane, F., Fite, A., Daboul, N., Al-Janabi, W., Msallaty, Z., Caruso, M. A., Lewis, M. K., Yi, Z., Diamond, M. P., Abou‐Samra, A., et al. (2015) · Journal of Diabetes Research · doi:10.1155/2015/102054 · Cited by 70
Yoo, D. Y., Yim, H. S., Jung, H. Y., Nam, S. M., Kim, J. W., Choi, J. H., Seong, J. K., Yoon, Y. S., Kim, D. W., & Hwang, I. K. (2016) · Journal of Veterinary Medical Science · doi:10.1292/jvms.15-0589 · Cited by 70
Martins, I. V. A., Rivers‐Auty, J., Allan, S. M., & Lawrence, C. B. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160640 · Cited by 70
Evaluation of rat insulin messenger RNA in pancreatic and extrapancreatic tissues
Giddings, S. J., Chirgwin, J. M., & Permutt, M. A. (1985) · Diabetologia · doi:10.1007/bf00283141 · Cited by 69
Wu, J. H., Haan, M. N., Liang, J., Ghosh, D., Gonzalez, H. M., & Herman, W. H. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(02)00464-7 · Cited by 68
Central Insulin Administration Improves Odor-Cued Reactivation of Spatial Memory in Young Men
Brünner, Y. F., Kofoet, A., Benedict, C., & Freiherr, J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3018 · Cited by 68
Malek‐Ahmadi, M. H., Beach, T. G., Obradov, A., Sue, L. I., Belden, C. M., Davis, K. J., Walker, D. G., Lue, L., Adem, A., & Sabbagh, M. N. (2013) · Current Alzheimer Research · doi:10.2174/15672050113109990006 · Cited by 67
Insulin Modulates In Vitro Secretion of Cytokines and Cytotoxins by Human Glial Cells
Spielman, L. J., Bahniwal, M., Little, J. P., Walker, D., & Klegeris, A. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150710104428 · Cited by 66
Hatfield, J. S., Millard, W. J., & Smith, C. J. V. (1974) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(74)90056-2 · Cited by 66
Diet‐induced obesity accelerates the onset of terminal phenotypes in α‐synuclein transgenic mice
Rotermund, C., Truckenmüller, F. M., Schell, H., & Kahle, P. J. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12813 · Cited by 66
The neuronal insulin receptor in its environment
Gralle, M. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13909 · Cited by 64
Unger, J. W., & Betz, M. J. (1998) · PubMed · doi:10.14670/hh-13.1215 · Cited by 63
Cardiovascular risk factors and frontotemporal dementia: a case–control study
Golimstok, Á., Cámpora, N., Rojas, J. I., Fernández, M. C., Elizondo, C. M., Soriano, E. R., & Cristiano, E. (2014) · Translational Neurodegeneration · doi:10.1186/2047-9158-3-13 · Cited by 62
Mechanisms of β‐cell functional adaptation to changes in workload
Wortham, M., & Sander, M. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12729 · Cited by 62
Hallschmid, M., Jauch-Chara, K., Korn, O., Mölle, M., Rasch, B., Born, J., Schultes, B., & Kern, W. (2010) · Diabetes · doi:10.2337/db09-1493 · Cited by 61
Cerebral haemodynamics, cognition and brain volumes in patients with type 2 diabetes
Brundel, M., van den Berg, E., Reijmer, Y. D., de Bresser, J., Kappelle, L. J., & Biessels, G. J. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.03.021 · Cited by 61
Insulin inhibits AMPA-induced neuronal damage via stimulation of protein kinase B (Akt)
Kim, S.-J., & Han, Y. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0163-6 · Cited by 60
Type 2 diabetes affects hippocampus volume differentially in men and women
Hempel, R., Onopa, R., & Convit, A. J. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1230 · Cited by 60
Intranasal Insulin Suppresses Systemic but Not Subcutaneous Lipolysis in Healthy Humans
Iwen, K. A., Scherer, T., Heni, M., Sayk, F., Wellnitz, T., Machleidt, F., Preissl, H., Häring, H.-U., Fritsche, A., Lehnert, H., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3169 · Cited by 59
Self-citationFadel, J. R., & Reagan, L. P. (2015) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2015.12.004 · Cited by 58
Disrupted resting-state attentional networks in T2DM patients
Xia, W., Wang, S., Rao, H., Spaeth, A. M., Wang, P., Yang, Y., Huang, R., Cai, R., & Sun, H. (2015) · Scientific Reports · doi:10.1038/srep11148 · Cited by 57
Zhang, Y.-W., Zhang, J., Liu, C., Wei, P., Zhang, X., Yuan, Q., Yin, X., Wei, L., Cui, J., & Wang, J. (2015) · Chinese Medical Journal · doi:10.4103/0366-6999.151082 · Cited by 57
Therapeutic targets of brain insulin resistance in sporadic Alzheimer s disease
de la Monte, S. M. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e482 · Cited by 57
Is type 2 diabetes related to leukoaraiosis? an updated review
Bene, A. D., Ciolli, L., Borgheresi, L., Poggesi, A., Inzitari, D., & Pantoni, L. (2015) · Acta Neurologica Scandinavica · doi:10.1111/ane.12398 · Cited by 56
Insulin, Synaptic Function, and Opportunities for Neuroprotection
Mielke, J. G., & Wang, Y.-T. (2011) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385506-0.00004-1 · Cited by 55
Glucose transport in primary cultured neurons
Heidenreich, K. A., Gilmore, P. R., & Garvey, W. T. (1989) · Journal of Neuroscience Research · doi:10.1002/jnr.490220405 · Cited by 55
Impaired glucose tolerance in midlife and longitudinal changes in brain function during aging
Thambisetty, M., Beason-Held, L. L., An, Y., Kraut, M., Metter, J., Egan, J., Ferrucci, L., O'Brien, R., & Resnick, S. M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.03.025 · Cited by 54
Hallschmid, M., Schultes, B., Marshall, L., Mölle, M., Kern, W., Bredthauer, J., Fehm, H. L., & Jan Born, A. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2202 · Cited by 50
Response of Human Oligodendrocyte Progenitors to Growth Factors and Axon Signals
Cui, Q., Fragoso, G., Miron, V. E., Darlington, P. J., Mushynski, W. E., Antel, J. P., & Almazán, G. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181ef3be4 · Cited by 50
Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease
Suzanne, M. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/482 · Cited by 50
Xia, W., Rao, H., Spaeth, A. M., Huang, R., Tian, S., Cai, R., Sun, J. L., & Wang, S. (2015) · Medicine · doi:10.1097/md.0000000000002231 · Cited by 44
Neural substrates of verbal memory impairments in adults with type 2 diabetes mellitus
Yau, P. L., Kluger, A., Borod, J. C., et al. (2014) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2013.869310 · Cited by 43
Insulin Modulation of Magnetoencephalographic Resting State Dynamics in Lean and Obese Subjects
Stingl, K. T., Kullmann, S., Guthoff, M., Heni, M., Fritsche, A., & Preissl, H. T. (2010) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2010.00157 · Cited by 41
Ye, P., Li, L., Lund, P. K., & D’Ercole, A. J. (2002) · Developmental Brain Research · doi:10.1016/s0165-3806(02)00355-3 · Cited by 40
The binding of insulin to cerebral capillaries and astrocytes of the rat
Albrecht, J., Wr√≥blewska, B., & Mossakowski, M. (1982) · Neurochemical Research · doi:10.1007/bf00965500 · Cited by 40
Impaired fasting glucose is associated with increased regional cerebral amyloid
Morris, J. K., Vidoni, E. D., Wilkins, H., Archer, A. E., Burns, N. C., Karcher, R. T., Graves, R. S., Swerdlow, R. H., Thyfault, J. P., & Burns, J. M. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.04.017 · Cited by 40
C-peptide immunoreactive neurons in human brain
Dorn, A., Rinne, A., Hahn, H.-J., Bernstein, H., & ZIEGLER, M. (1982) · Acta Histochemica · doi:10.1016/s0065-1281(82)80080-9 · Cited by 37
Xia, W., Wang, S., Spaeth, A. M., Rao, H., Wang, P., Yang, Y., Huang, R., Cai, R., & Sun, H. (2015) · BioMed Research International · doi:10.1155/2015/719076 · Cited by 35
New animal models of Alzheimer’s disease that display insulin desensitization in the brain
Gao, C., Liu, Y., Li, L., & Hölscher, C. (2013) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0034 · Cited by 32
Marano, C. M., Workman, C. I., Lyman, C. H., Kramer, E., Hermann, C. R., Ma, Y., DHAWAN, V. M., Chaly, T., Eidelberg, D., & Smith, G. S. (2014) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2014.01.009 · Cited by 30
Cerebrospinal fluid insulin during non-neurological surgery
Bromander, S., Anckarsäter, R., Åhrén, B., Kristiansson, M., Blennow, K., Holmäng, A. B., Zetterberg, H., Anckarsäter, H. S., & Wass, C. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0456-x · Cited by 29
Evaluation of the lack of anorectic effect of intracerebroventricular insulin in rats
Jessen, L., Clegg, D. J., & Bouman, S. D. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90736.2008 · Cited by 29
Glucose improves object-location binding in visual-spatial working memory
Stollery, B. T., & Christian, L. M. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4125-5 · Cited by 29
Komori, T., Morikawa, Y., Tamura, S., Doi, A., Nanjo, K., & Senba, E. (2005) · Brain Research · doi:10.1016/j.brainres.2005.04.079 · Cited by 28
Insulin Treatment in Psychiatry
Rinkel, M., & Himwich, H. E. (1960) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196003000-00061 · Cited by 28
Identification of diabetes-related dementia: Longitudinal perfusion SPECT and amyloid PET studies
Fukasawa, R., Hanyu, H., Shimizu, S., Kanetaka, H., Sakurai, H., & Ishii, K. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.12.023 · Cited by 28
Li, Y., Li, L., & Hölscher, C. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0018 · Cited by 28
Metaflammasome components in the human brain: a role in dementia with Alzheimer's pathology?
Taga, M. F., Minett, T., Classey, J. D., Matthews, F. E., Brayne, C., Ince, P. G., Nicoll, J. A. R., Hugon, J., Boche, D., & CFAS, M. (2016) · Brain Pathology · doi:10.1111/bpa.12388 · Cited by 27
Tomita, N., Furukawa, K., Okamura, N., Tashiro, M., Une, K., Furumoto, S., Iwata, R., Yanai, K., Kudo, Y., & Arai, H. (2012) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2012.00880.x · Cited by 24
Ajaya, B., & Ps, H. (1982) · PubMed · Cited by 23
Hsu, F., Yuan, M., Bowden, D. W., Xu, J., Smith, S. C., Wagenknecht, L. E., Langefeld, C. D., Divers, J., Register, T. C., Carr, J. J., et al. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.08.012 · Cited by 22
Crane, P. K., Walker, R. L., Sonnen, J. A., Gibbons, L. E., Melrose, R. J., Hassenstab, J. J., Keene, C. D., Postupna, N. O., Montine, T. J., & Larson, E. B. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.07.021 · Cited by 18
Neuropathology of type 2 diabetes: a short review on insulin-related mechanisms
Guerrero‐Berroa, E., Schmeidler, J., & Beeri, M. S. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.01.019 · Cited by 14
Insulin Treatment in Psychiatry
Rosenthal, M. (1960) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-196008000-00014 · Cited by 9
MK-801-induced expression of Fos protein family members in the rat retrosplenial granular cortex
Zhang, X., Fan, X.-D., Mohapel, P., Yu, P. H., & Boulton, A. A. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990901)57:5 · Cited by 7
Flagged first, then by citations
Cited by
Sorted by citations
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954
Effects of intermittent fasting on health, aging, and disease
de Cabo, R., & Mattson, M. P. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1905136 · Cited by 1,605
Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications
Biessels, G. J., & Despa, F. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0048-7 · Cited by 1,454
Metadata
- Authors
- Arnold, S. E., Arvanitakis, Z., Macauley-Rambach, S. L., Koenig, A. M., Wang, H.-Y., Ahima, R. S., Craft, S., Gandy, S., Buettner, C., Stoeckel, L. E., Holtzman, D. M., & Nathan, D. M.
- Affiliations
- Harvard University (US)
- Rush University Medical Center (US)
- City University of New York (US)
- Johns Hopkins University (US)
- Atrium Health Wake Forest Baptist (US)
- Icahn School of Medicine at Mount Sinai (US)
- Washington University in St. Louis (US)
- Corresponding author
- Arnold, Steven E.
- ORCID
- Venue
- Nature Reviews Neurology
- Published
- 2018-01-29
- Volume
- 14
- Issue
- 3
- Pages
- 168-181
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- PMC
- PMC6098968
- OpenAlex
- W2786962139
- Cited by
- 1,597
- References
- 285
- Citations by year
- 2026: 223 · 2025: 244 · 2024: 218 · 2023: 205 · 2022: 210 · 2021: 176 · 2020: 163 · 2019: 102 · 2018: 52
- FWCI
- 16.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Rutgers University Community Repository (Rutgers University) (submittedVersion)
- Funders
- BrightFocus Foundation
- National Institutes of Health
- National Institute on Aging (R21AG051958)
- National Institute of Neurological Disorders and Stroke (R01NS084965)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- brain insulin resistance, type 2 diabetes, Alzheimer's disease, Alzheimer's disease and related dementias, insulin signaling, cognitive impairment, obesity, glia, neurons, neuropathology, comorbidities, aging
- MeSH terms
- Brain, Dementia, Diabetes Mellitus, Type 2, Humans, Insulin, Insulin Resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
